Skip to content
Trial Eligibility
Menu

Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 4

NCT07679581

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of two different strains of cannabis flower one day and while not intoxicated another day. Event-related potentials (ERPs) are measured via electroencephalogram (EEG) during the recognition memory task. Blood is collected to quantify THC and CBD exposure.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Cannabis
  • Memory
  • Electroencephalography

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
21 to 40 years
Sex
All
Healthy volunteers
Accepted
Sponsor
L. Cinnamon Bidwell
Last updated on ClinicalTrials.gov
July 1, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • Center for Innovation and Creativity (CINC) · Boulder, CO

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.